Evidence map›Paper›PMID 29436686›Full record

ArticleOncology reports2018

Downregulation of the long non-coding RNA XLOC_010588 inhibits the invasion and migration of colorectal cancer.

Yue Li, Lin Zhao, Yining Zhang, Lin Guan, Huijing Zhang, Huan Zhou, Tong Gao, Peng Miao, Mingjun Sun

Abstract read
In one paragraph

Article in Oncology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. LOC101060264 Silencing Suppresses Invasion and Metastasis of Human Colon Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yue LiDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Lin ZhaoDepartment of Pharmacology, School of Pharmaceutical Sciences, China Medical University, Shenyang, Liaoning 110122, P.R. China.
Yining ZhangDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Lin GuanDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Huijing ZhangDepartment of Endoscopy, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Huan ZhouDepartment of Endoscopy, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Tong GaoDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Peng MiaoDepartment of Anal and Intestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Mingjun SunDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) have emer-ged as major players in many biological and pathological processes; however, investigation into the function of lncRNAs in the development and progression of cancer is in its infancy. Therefore, clarification of the mechanism by which cancer‑related lncRNAs function is of critical importance in research on tumorigenesis. It has been demonstrated that the lncRNA XLOC_010588 is expressed at a low level in cervical cancer, and that this has significant impact on the proliferation of cervical cancer cells. However, the expression pattern and functional roles of XLOC_010588 in colorectal cancer (CRC) remain unclear. In the present study, it was demonstrated that the expression of XLOC_010588 was significantly higher in CRC tissues when compared with that in adjacent normal tissues, and that XLOC_010588 was closely associated with metastasis and poor prognosis, thus indicating that XLOC_010588 may function as an oncogene. Additionally, downregulation of XLOC_010588 expression markedly inhibited the invasion and migration of CRC cells. Furthermore, it was demonstrated that XLOC_010588 may regulate the progression of CRC via the epithelial-mesenchymal transition (EMT) pathway. Notably, downregulation of XLOC_010588 inhibited the invasion and migration of CRC cells by regulating genes associated with EMT. Our findings revealed that XLOC_010588 may be considered as a novel potential diagnostic biomarker in CRC.

Indexed as

AgedApoptosisCarcinogenesisCell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessRNA, Long NoncodingRNA, Long NoncodingTUSC8 long non-coding RNA, human

Identifiers

PMID29436686
PMCPMC5868398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.